TGFBI expression reduces in vitro and in vivo metastatic potential of lung and breast tumor cells

Cancer Letters

Volumn 308, Issue 1, 2011, Pages 23-32

  Wen, Gengyun ^a   Partridge, Michael A ^a   Li, Bingyan ^a,b   Hong, Mei ^a,e   Liao, Wupeng ^d   Cheng, Simon K ^d   Zhao, Yongliang ^a   Calaf, Gloria M ^a,f   Liu, Tian ^d   Zhou, Jun ^d   Zhang, Zengli ^b   Hei, Tom K ^a,b,c  

^a Columbia University ^*  (United States)

^b SOOCHOW UNIVERSITY   (China)

^c Columbia University Medical Center ^*  (United States)

^d NewYork Presbyterian Hospital   (United States)

^e SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^f Instituto de Alta Investigación   (Chile)

Author keywords

Adhesion mediated signaling; Extracellular matrix; Metastasis; Mouse model; TGFBI

Indexed keywords

GELATINASE A; GELATINASE B; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA INDUCED PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL ADHESION; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CYTOSKELETON; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; NEOPLASM METASTASIS; SIGNAL TRANSDUCTION; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

MUS;

EID: 79958140475     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.04.010     Document Type: Article

References (45)

1. Gupta G.P., Massague J. Cancer metastasis: building a framework. Cell 2006, 127:679-695.
2. Arribas J. Matrix metalloproteases and tumor invasion. N. Engl. J. Med. 2005, 352:2020-2021.
3. Coussens L.M., Fingleton B., Matrisian L.M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002, 295:2387-2392.
4. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
5. Lu Z., Jiang G., Blume-Jensen P., Hunter T. Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol. Cell. Biol. 2001, 21:4016-4031.
6. Humphries M.J., Olden K., Yamada K.M. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 1986, 233:467-470.
7. Vollmers H.P., Imhof B.A., Braun S., Waller C.A., Schirrmacher V., Birchmeier W. Monoclonal antibodies which prevent experimental lung metastases. Interference with the adhesion of tumour cells to laminin. FEBS Lett. 1984, 172:17-20.
8. Kren A., Baeriswyl V., Lehembre F., Wunderlin C., Strittmatter K., Antoniadis H., Fassler R., Cavallaro U., Christofori G. Increased tumor cell dissemination and cellular senescence in the absence of beta1-integrin function. EMBO J. 2007, 26:2832-2842.
9. Skonier J., Neubauer M., Madisen L., Bennett K., Plowman G.D., Purchio A.F. Plowman, A.F. Purchio, cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-β. DNA Cell Biol. 1992, 11:511-522.
10. Zhao Y.L., Piao C.Q., Hei T.K. Downregulation of Betaig-h3 gene is causally linked to tumorigenic phenotype in asbestos treated immortalized human bronchial epithelial cells. Oncogene 2002, 21:7471-7477.
11. Thapa N., Lee B.H., Kim I.S. TGFBIp/betaig-h3 protein: a versatile matrix molecule induced by TGF. Int. J. Biochem. Cell Biol. 2007, 39:2183-2194.
12. Zhang Y., Wen G., Shao G., Wang C., Lin C., Fang H., Balajee A.S., Bhagat G., Hei T.K., Zhao Y. TGFBI deficiency predisposes mice to spontaneous tumor development. Cancer Res. 2009, 69:37-44.
13. Nabokikh A., Ilhan A., Bilban M., Gartner W., Vila G., Niederle B., Nielsen J.H., Wagner O., Base W., Luger A., Wagner L. Reduced TGF-beta1 expression and its target genes in human insulinomas. Exp. Clin. Endocrinol. Diabetes 2007, 115:674-682.
14. Becker J., Erdlenbruch B., Noskova I., Schramm A., Aumailley M., Schorderet D.F., Schweigerer L. Keratoepithelin suppresses the progression of experimental human neuroblastomas. Cancer Res. 2006, 66:5314-5321.
15. Munier F.L., Korvatska E., Djemai A., Le Paslier D., Zografos L., Pescia G., Schorderet D.F. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat. Genet. 1997, 15:247-251.
16. Zhao Y., El-Gabry M., Hei T.K. Loss of Betaig-h3 protein is frequent in primary lung carcinoma and related to tumorigenic phenotype in lung cancer cells. Mol. Carcinog. 2006, 45:84-92.
17. Shao G., Berenguer J., Borczuk A.C., Powell C.A., Hei T.K., Zhao Y. Epigenetic inactivation of Betaig-h3 gene in human cancer cells. Cancer Res. 2006, 66:4566-4573.
18. Billings P.C., Whitbeck J.C., Adams C.S., Abrams W.R., Cohen A.J., Engelsberg B.N., Howard P.S., Rosenbloom J. The transforming growth factor-beta-inducible matrix protein (beta)ig-h3 interacts with fibronectin. J. Biol. Chem. 2002, 277:28003-28009.
19. Ma C., Rong Y., Radiloff D.R., Datto M.B., Centeno B., Bao S., Cheng A.W., Lin F., Jiang S., Yeatman T.J., Wang X.F. Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes. Dev. 2008, 22:308-321.
20. Partridge M.A., Marcantonio E.E. Initiation of attachment and generation of mature focal adhesions by integrin-containing filopodia in cell spreading. Mol. Biol. Cell 2006, 17:4237-4248.
21. Cavallaro U., Christofori G. Multitasking in tumor progression: signaling functions of cell adhesion molecules. Ann. N. Y. Acad. Sci. 2004, 1014:58-66.
22. Turner C.E. Paxillin interactions. J. Cell Sci. 2000, 113 Pt 23:4139-4140.
23. Mitra S.K., Schlaepfer D.D. Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr. Opin. Cell Biol. 2006, 18:516-523.
24. Frisch S.M., Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 1994, 124:619-626.
25. Xiong W.C., Mei L. Roles of FAK family kinases in nervous system. Front Biosci. 2003, 8:s676-82.
26. Roelle S., Grosse R., Buech T., Chubanov V., Gudermann T. Essential role of Pyk2 and Src kinase activation in neuropeptide-induced proliferation of small cell lung cancer cells. Oncogene 2008, 27:1737-1748.
27. Yuan T.C., Lin F.F., Veeramani S., Chen S.J., Earp H.S., Lin M.F. ErbB-2 via PYK2 upregulates the adhesive ability of androgen receptor-positive human prostate cancer cells. Oncogene 2007, 26:7552-7559.
28. Schmalfeldt B., Prechtel D., Harting K., Spathe K., Rutke S., Konik E., Fridman R., Berger U., Schmitt M., Kuhn W., Lengyel E. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin. Cancer Res. 2001, 7:2396-2404.
29. Skonier J., Bennett K., Rothwell V., Kosowski S., Plowman G., Wallace P., Edelhoff S., Disteche C., Neubauer M., Marquardt H. Beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol. 1994, 13:571-584.
30. Moser T.L., Young T.N., Rodriguez G.C., Pizzo S.V., Bast R.C., Stack M.S. Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma. Int. J. Cancer 1994, 56:552-559.
31. Young T.N., Rodriguez G.C., Rinehart A.R., Bast R.C., Pizzo S.V., Stack M.S. Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2. Gynecol. Oncol. 1996, 62:89-99.
32. Fishman D.A., Bafetti L.M., Banionis S., Kearns A.S., Chilukuri K., Stack M.S. Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells. Cancer 1997, 80:1457-1463.
33. Afzal S., Lalani el-N., Foulkes W.D., Boyce B., Tickle S., Cardillo M.R., Baker T., Pignatelli M., Stamp G.W. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines. Lab. Invest. 1996, 74:406-421.
34. Nam J.O., Jeong H.W., Lee B.H., Park R.W., Kim I.S. Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of betaig-h3, via alphavbeta3 integrin. Cancer Res. 2005, 65:4153-4161.
35. Zhao Y.L., Piao C.Q., Hei T.K. Overexpression of Betaig-h3 gene downregulates integrin alpha5beta1 and suppresses tumorigenicity in radiation-induced tumorigenic human bronchial epithelial cells. Brit. J. Cancer 2002, 86:1923-1928.
36. Ahmed A.A., Mills A.D., Ibrahim A.E., Temple J., Blenkiron C., Vias M., Massie C.E., Iyer N.G., McGeoch A., Crawford R., Nicke B., Downward J., Swanton C., Bell S.D., Earl H.M., Laskey R.A., Caldas C., Brenton J.D. The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel. Cancer Cell 2007, 12:514-527.
37. Palazzo A.F., Eng C.H., Schlaepfer D.D., Marcantonio E.E., Gundersen G.G. Localized stabilization of microtubules by integrin- and FAK-facilitated Rho signaling. Science 2004, 303:836-839.
38. San R.H., Laspia M.F., Soiefer A.I., Maslansky C.J., Rice J.M., Williams G.M. A survey of growth in soft agar and cell surface properties as markers for transformation in adult rat liver epithelial-like cell cultures. Cancer Res. 1979, 39:1026-1034.
39. Westermarck J., Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999, 13:781-792.
40. McCawley L.J., Matrisian L.M. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol. Med. Today 2000, 6:149-156.
41. Gao C.F., Xie Q., Su Y.L., Koeman J., Khoo S.K., Gustafson M., Knudsen B.S., Hay R., Shinomiya N., Vande Woude G.F. Proliferation and invasion: plasticity in tumor cells. Proc. Natl. Acad. Sci. USA 2005, 102:10528-10533.
42. Al-Mehdi A.B., Tozawa K., Fisher A.B., Shientag L., Lee A., Muschel R.J. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat. Med. 2000, 6:100-102.
43. Bradley M.O., Kraynak A.R., Storer R.D., Gibbs J.B. Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes. Proc. Natl. Acad. Sci. USA 1986, 83:5277-5281.
44. Yang J., Mani S.A., Weinberg R.A. Exploring a new twist on tumor metastasis. Cancer Res. 2006, 66:4549-4552.
45. Ween M.P., Lokman N.A., Hoffmann P., Rodgers R.J., Ricciardelli C., Oehler M.K. Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells. Intl. J. Cancer 2011, 128:1570-1584.